Nilima Dinesh Kumar

Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics

Rick Oerlemans, Angel J. Ruiz‐Moreno, Yingying Cong et al. · RSC Medicinal Chemistry · 2020 · 84 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air–Liquid Interface Cultured Human Primary Bronchial Epithelial Cells

Bram M. ter Ellen, Nilima Dinesh Kumar, Ellen M. Bouma et al. · Viruses · 2021 · 82 citations · Full text

Life Sciences, Infectious Diseases, Medicinal Chemistry +16

Inhibition of IRGM establishes a robust antiviral immune state to restrict pathogenic viruses

Parej Nath, Nishant Ranjan Chauhan, Kautilya Kumar Jena et al. · EMBO Reports · 2021 · 31 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

Resveratrol And Pterostilbene Potently Inhibit SARS-CoV-2 Replication In Vitro

Bram M. ter Ellen, Nilima Dinesh Kumar, Ellen M. Bouma et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 26 citations

Life Sciences, Infectious Diseases, Medicinal Chemistry +14

Moxidectin and Ivermectin Inhibit SARS-CoV-2 Replication in Vero E6 Cells but Not in Human Primary Bronchial Epithelial Cells

Nilima Dinesh Kumar, Bram M. ter Ellen, Ellen M. Bouma et al. · Antimicrobial Agents and Chemotherapy · 2021 · 25 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Virology +8